专利检索 ap:("Vertex Pharmaceuticals Incorporated") AND inv:"Cavan McKeon BLIGH" 第 1 页

1.

发明公开
MODULATORS OF ALPHA-1 ANTITRYPSIN 审中-公开

公开(公告)号：US20240336614A1

公开(公告)日：2024-10-10

申请号：US18487690

申请日：2023-10-16

申请人： Vertex Pharmaceuticals Incorporated

发明人： Upul Keerthi BANDARAGE , Cavan McKeon BLIGH , Diane BOUCHER , Michael John BOYD , Michael Aaron BRODNEY , Michael Philip CLARK , Veronique DAMAGNEZ , Lev Tyler Dewey FANNING , Robert Francis FIMOGNARI , Gabrielle Simone FLEMING , Kevin James GAGNON , Pedro Manuel GARCIA BARRANTES , Robert Daniel GIACOMETTI , Simon GIROUX , Ronald Lee GREY, JR. , Samantha GUIDO , Amy Beth HALL , Sarah Carol HOOD , Dennis James HURLEY , Mac Arthur JOHNSON, JR. , Peter Jones , Sarathy KESAVAN , Mei-Hsiu LAI , Siying LIU , Adam LOOKER , Brad MAXWELL , John Patrick MAXWELL , Ales MEDEK , Philippe Marcel NUHANT , Kirk Alan OVERHOFF , Setu RODAY , Stefanie ROEPER , Steven M. RONKIN , Rupa SAWANT , Yi SHI , Muna SHRESTHA , Marisa SPOSATO , Kathy STAVROPOULOS , Rebecca Jane SWETT , Timothy Lewis TAPLEY , Qing TANG , Stephen THOMSON , Jinwang XU , Mariam ZAKY , Kevin Michael COTTRELL

IPC分类号： C07D487/04 , A61K9/16 , A61K31/4162 , C07D491/18 , C07D513/04 , C07D519/00 , C07F9/6561 , C07H15/26

CPC分类号： C07D487/04 , A61K9/1635 , A61K9/1652 , A61K31/4162 , C07D491/18 , C07D513/04 , C07D519/00 , C07F9/6561 , C07H15/26 , C07B2200/13

摘要： The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I):

tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.

2.

发明公开
PROCESSES FOR PREPARING MODULATORS OF ALPHA-1 ANTITRYPSIN 审中-公开

公开(公告)号：US20230279010A1

公开(公告)日：2023-09-07

申请号：US18018245

申请日：2021-07-26

申请人： Vertex Pharmaceuticals Incorporated

发明人： Cavan McKeon BLIGH , Robert Daniel GIACOMETTI , Cristian HARRISON , Stephen W. LAWS , Adam LOOKER , Stefanie ROEPER

IPC分类号： C07D487/04 , C07D231/56 , C07D309/06

CPC分类号： C07D487/04 , C07D231/56 , C07D309/06

摘要： This disclosure provides large-scale processes for preparing a modulator of alpha-1 antitrypsin (AAT) activity that may be useful for treating alpha-1 antitrypsin deficiency (AATD), such as 4-(5-(4-fluorophenyl)-6-(tetrahydro-2H-pyran -4-yl)-1,5-dihydropyrrolo[2,3-f]indazol-7-yl)benzoic acid (Compound 1), 3-[5-(4-fluorophenyl)-6-isopropyl-1H-pyrrolo[2,3-f]inda-zol-7-yl]propanoic acid (Compound 2), or a pharmaceutically acceptable salt of any of the foregoing.